Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances •
Avid To Supply Arius Onco-Antibody for Trials

December 5, 2007
Avid Bioservices has signed a manufacturing supply and technology transfer agreement with Arius Research. The agreement covers Arius' lead cancer stem cell antibody, which targets a novel epitope of CD44 found in breast, colon and prostate cancers. A…  Read More »
Quest Pharmaceutical Re-Brands to QPS

December 4, 2007
Quest Pharmaceutical Services, LLC, a GLP-compliant CRO providing testing services to support preclinical and clinical research and development, has formally changed its name to QPS, LLC. The company commissioned independent market research to eva…  Read More »
J&J Units Submit Psoriasis MAb

December 4, 2007
Two Johnson & Johnson subsidiaries, Centocor, Inc. and Janssen-Cilag International NV, have submitted marketing approval applications for ustekinumab (CNTO 1275) in the U.S. and Europe for the treatment of adult patients with chronic moderate to…  Read More »
CMC Expands Bio-CMO Footprint with Icos Purchase

December 4, 2007
CMC Biopharmaceuticals A/S has reached an agreement with Lilly to buy the biologics development and manufacturing operation of ICOS Corp., which Lilly bought on in January 2007. CMC, a Copenhagen, Denmark-based bio-CMO, will purchase the biologics fa…  Read More »
BioReliance Corp.

December 3, 2007
David A. Dodd has been named president, chief executive officer and chairman at BioReliance Corp. From 2000 through 2006, Mr. Dodd served as president and chief executive officer of Serologicals Corp., a publicly traded company that was sold to Milli…  Read More »
Novartis, MorphoSys Enter 10-Year Antibody R&D Pact

December 3, 2007
Novartis and MorphoSys AG have formed a comprehensive, 10-year, $600 million strategic alliance for the discovery and development of biopharmaceuticals. The deal is aimed at establishing a pipeline of innovative drugs, and establishes Novartis as Mor…  Read More »
Aptuit Completes Evotec CPD Acquisition

December 3, 2007
Aptuit, Inc. has completed the acquisition of Evotec's Chemical and Pharmaceutical Development (CPD) business. The move allows Aptuit to integrate an API facility in Oxford, England and a recently expanded parenteral fill/finish facility in Glasgow,…  Read More »
AZ Completes ZEST Enrollment

November 30, 2007
AstraZeneca has completed enrollment of patients in the ZEST (Zactima Efficacy Study versus Tarceva) study, the first of four Phase III trials for the investigational once-daily oral anti-cancer drug vandetanib. Data from the study is expected in 200…  Read More »
LifeCycle Pharma A/S

November 30, 2007
Hans Christian Teisen has been named senior vice president and chief financial officer at LifeCycle Pharma. He replaces Michael Wolff Jensen, executive vice president and chief financial officer, who has decided to leave the company, effective March…  Read More »
IVT, Dalton Scale Up Vax Platform

November 30, 2007
ImmunoVaccine Technologies Inc. (IVT) has successfully scaled-up the manufacturing process for its vaccine platform, Vaccimax. The manufacturing development was performed by Dalton Pharma Services. VacciMax is a vaccine-enhancement platform compri…  Read More »
Sanofi Bumps Up Regeneron Stake

November 29, 2007
Regeneron Pharmaceuticals and Sanofi-Aventis have entered a new collaboration, which will include a greater SA stake in the biopharma. The companies will work to discover, develop, and commercialize fully-human therapeutic antibodies utilizing Regene…  Read More »
QLT Considers Selloff

November 28, 2007
QLT Inc. has formed a Special Committee to "review all strategic alternatives available," according to a company statement. The committee, comprised of three independent directors from the board, has appointed Morrison & Foerster, LLP a…  Read More »
Baxter, DynPort Receive HHS Flu Vax Funds

November 28, 2007
DynPort Vaccine Co. and Baxter International have received a $201.2 million contract modification from the U.S. Department of Health and Human Services (HHS) for the development of Baxter's cell-cultured seasonal and pandemic influenza candidate vacc…  Read More »
Gene Logic

November 28, 2007
Bethany Mancilla has been promoted to senior vice president, business development at Gene Logic, where she will lead the company's partnering and licensing efforts. Since July 2004, Ms. Mancilla has been involved in the formation and development of G…  Read More »
GSK, Pharmacopeia Pact Yields New Leads

November 27, 2007
Pharmacopeia has identified a pair of new lead compounds for advancement in its alliance with GlaxoSmithKline. The first of the lead compounds forms the basis of a new lead optimization program focused on identifying a treatment for respiratory disea…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: